Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis

Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis

Forty patients with a diagnosis of presumptive bacterial conjunctivitis were treated with either trimethoprim-polymyxin or chloramphenicol ophthalmic solutions in a randomized, double-blind trial. No significant differences could be demonstrated between the results of 7-days' treatment with the...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1982), 4 vom: 05., Seite 274-7
1. Verfasser: van Rensburg, S F (VerfasserIn)
Weitere Verfasser: Gibson, J R, Harvey, S G, Burke, C A
Format: Aufsatz
Sprache:English
Veröffentlicht: 1982
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Drug Combinations Ophthalmic Solutions Polymyxins Chloramphenicol 66974FR9Q1 Trimethoprim mehr... AN164J8Y0X Polymyxin B J2VZ07J96K
LEADER 01000caa a22002652c 4500
001 NLM062699792
003 DE-627
005 20250128091314.0
007 tu
008 231221s1982 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0209.xml 
035 |a (DE-627)NLM062699792 
035 |a (NLM)6292957 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a van Rensburg, S F  |e verfasserin  |4 aut 
245 1 0 |a Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis 
264 1 |c 1982 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 07.01.1983 
500 |a Date Revised 30.11.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Forty patients with a diagnosis of presumptive bacterial conjunctivitis were treated with either trimethoprim-polymyxin or chloramphenicol ophthalmic solutions in a randomized, double-blind trial. No significant differences could be demonstrated between the results of 7-days' treatment with the two preparations and both solutions were found to be effective in improving the signs and symptoms of surface ocular bacterial infection. No adverse reactions were reported in either treatment group 
650 4 |a Clinical Trial 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Randomized Controlled Trial 
650 7 |a Drug Combinations  |2 NLM 
650 7 |a Ophthalmic Solutions  |2 NLM 
650 7 |a Polymyxins  |2 NLM 
650 7 |a Chloramphenicol  |2 NLM 
650 7 |a 66974FR9Q1  |2 NLM 
650 7 |a Trimethoprim  |2 NLM 
650 7 |a AN164J8Y0X  |2 NLM 
650 7 |a Polymyxin B  |2 NLM 
650 7 |a J2VZ07J96K  |2 NLM 
700 1 |a Gibson, J R  |e verfasserin  |4 aut 
700 1 |a Harvey, S G  |e verfasserin  |4 aut 
700 1 |a Burke, C A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 3(1982), 4 vom: 05., Seite 274-7  |w (DE-627)NLM023961570 
773 1 8 |g volume:3  |g year:1982  |g number:4  |g day:05  |g pages:274-7 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 3  |j 1982  |e 4  |b 05  |h 274-7